The role of therapeutic apheresis in the management of IBD

The primary goal when treating ulcerative colitis is to help patients regulate their immune systems better. However, current approved treatments do not work for all patients or do not control the disease all the time.

Several studies have suggested that GMA may be effective and safe in patients with IBD, especially in mild to moderate chronically active UC. It is especially useful in patients who do not respond to or are dependent on corticosteroids, because GMA can help reduce or withdraw them. GMA is also effective after loss of response to immunosuppressants or biologics and to replace toxic drug treatments. In addition, no adverse or very minor events have been reported.

This high-level medical e-learning webinar featuring leading Italian experts in IBD management will discuss and share experiences and opinions on GMA in IBD patients, as well as review existing evidence supporting its use.